Abstract
Background
Surgical resection of glioblastoma (GBM) remains a cornerstone in the current treatment paradigm. The postoperative evolution of hydrocephalus necessitating ventriculoperitoneal shunting (VPS) continues to be defined. Correspondingly the objective of this study was to aggregate pertinent metadata to better define the clinical course of VPS for hydrocephalus following glioblastoma surgery in light of contemporary management.
Methods
Searches of multiple electronic databases from inception to November 2023 were conducted following PRISMA guidelines. Articles were screened against pre-specified criteria. Outcomes were pooled by random-effects meta-analyses where possible.
Results
A total of 12 cohort studies satisfied all selection criteria, describing a total of 6,098 glioblastoma patients after surgery with a total of 261 (4%) of patients requiring postoperative VPS for hydrocephalus. Meta-analysis demonstrated the estimated pooled rate of symptomatic improvement following VPS was 78% (95% CI 66–88), and the estimated pooled rate of VPS revision was 24% (95% CI 16–33). Pooled time from index glioblastoma surgery to VPS surgery was 4.1 months (95% CI 2.8–5.3), and pooled survival time for index VPS surgery was 7.3 months (95% CI 5.4–9.4). Certainty of these outcomes were limited by the heterogenous and palliative nature of postoperative glioblastoma management.
Conclusions
Of the limited proportion of glioblastoma patients requiring VPS surgery for hydrocephalus after index surgery, 78% patients are expected to show symptom improvement, and 24% can expect to undergo revision surgery. An individualized approach to each patient is required to optimize both index glioblastoma and VPS surgeries to account for anatomy and goals of care given the poor prognosis of this tumor overall.
Similar content being viewed by others
Data availability
No datasets were generated or analysed during the current study.
References
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. https://doi.org/10.1056/NEJMoa043330
Molinaro AM, Hervey-Jumper S, Morshed RA, Young J, Han SJ, Chunduru P et al (2020) Association of Maximal Extent of Resection of contrast-enhanced and non-contrast-enhanced Tumor with Survival within Molecular subgroups of patients with newly diagnosed Glioblastoma. JAMA Oncol 6(4):495–503. https://doi.org/10.1001/jamaoncol.2019.6143
Kaplan JG, DeSouza TG, Farkash A, Shafran B, Pack D, Rehman F et al (1990) Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, Lymphomas and leukemias. J Neurooncol 9(3):225–229. https://doi.org/10.1007/bf02341153
Inamasu J, Nakamura Y, Saito R, Kuroshima Y, Mayanagi K, Orii M et al (2003) Postoperative communicating hydrocephalus in patients with supratentorial malignant glioma. Clin Neurol Neurosurg 106(1):9–15. https://doi.org/10.1016/s0303-8467(03)00060-x
El Rahal A, Cipriani D, Fung C, Hohenhaus M, Sveikata L, Straehle J et al (2022) Hydrocephalus Shunting in Supratentorial Glioblastoma: functional outcomes and management. Front Oncol 12:796105. https://doi.org/10.3389/fonc.2022.796105
Moher D, Liberati A, Tetzlaff J, Althman D (2009) Preferred reporting items for systematic reviews and Meta-analyses: the PRISMA Statement. PloS Med 6(7):e1000097. doi:10.1371/.
Lu VM, Graffeo CS, Perry A, Link MJ, Meyer FB, Dawood HY et al (2020) Pearls for interpreting neurosurgical systematic reviews and Meta-analyses: lessons from a collaborative effort. Neurosurgery. https://doi.org/10.1093/neuros/nyaa027
Freeman MF, Tukey JW (1950) Transformations related to the angular and the Square Root. Ann Math Statist 21(4):607–611. https://doi.org/10.1214/aoms/1177729756
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ: Br Med J 327(7414):557–560
Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research ed) 315(7109):629–634
Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455–463
Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S et al (2004) Grading quality of evidence and strength of recommendations. BMJ (Clinical Research ed) 328(7454):1490. https://doi.org/10.1136/bmj.328.7454.1490
Hönikl LS, Lange N, Barz M, Negwer C, Meyer B, Gempt J et al (2022) Postoperative communicating hydrocephalus following glioblastoma resection: incidence, timing and risk factors. Front Oncol 12:953784. https://doi.org/10.3389/fonc.2022.953784
Hong B, Polemikos M, Heissler HE, Hartmann C, Nakamura M, Krauss JK (2018) Challenges in cerebrospinal fluid shunting in patients with glioblastoma. Fluids Barriers CNS 15(1):16. https://doi.org/10.1186/s12987-018-0101-x
Beez T, Burgula S, Kamp M, Rapp M, Steiger H-J, Sabel M (2018) Symptomatic communicating hydrocephalus in a contemporary cohort of high grade glioma patients. Br J Neurosurg 32(1):68–72. https://doi.org/10.1080/02688697.2017.1380780
Behling F, Kaltenstadler M, Noell S, Schittenhelm J, Bender B, Eckert F et al (2017) The prognostic impact of ventricular opening in glioblastoma Surgery: a retrospective single Center Analysis. World Neurosurg 106:615–624. https://doi.org/10.1016/j.wneu.2017.07.034
Castro BA, Imber BS, Chen R, McDermott MW, Aghi MK (2017) Ventriculoperitoneal Shunting for Glioblastoma: risk factors, indications, and Efficacy. Neurosurgery 80(3):421–430. https://doi.org/10.1227/neu.0000000000001263
Fischer CM, Neidert MC, Péus D, Ulrich NH, Regli L, Krayenbühl N et al (2014) Hydrocephalus after resection and adjuvant radiochemotherapy in patients with glioblastoma. Clin Neurol Neurosurg 120:27–31. https://doi.org/10.1016/j.clineuro.2014.02.012
Onuma K, Ishikawa E, Matsuda M, Hirata K, Osuka S, Yamamoto T et al (2013) Clinical characteristics and neuroimaging findings in 12 cases of recurrent glioblastoma with communicating hydrocephalus. Neurol Med Chir (Tokyo) 53(7):474–481. https://doi.org/10.2176/nmc.53.474
Montano N, D’Alessandris QG, Bianchi F, Lauretti L, Doglietto F, Fernandez E et al (2011) Communicating hydrocephalus following Surgery and adjuvant radiochemotherapy for glioblastoma. J Neurosurg 115(6):1126–1130. https://doi.org/10.3171/2011.8.Jns11738
Roth J, Constantini S, Blumenthal DT, Ram Z (2008) The value of ventriculo-peritoneal shunting in patients with Glioblastoma Multiforme and ventriculomegaly. Acta Neurochir (Wien) 150(1):41–46 discussion 6–7. https://doi.org/10.1007/s00701-007-1454-0
Marquardt G, Setzer M, Lang J, Seifert V (2002) Delayed hydrocephalus after resection of supratentorial malignant gliomas. Acta Neurochir (Wien) 144(3):227–231 discussion 31. https://doi.org/10.1007/s007010200030
Hönikl LS, Lange N, Meyer B, Gempt J, Meyer HS (2023) Postoperative communicating Hydrocephalus following Grade 2/3 Glioma Resection: incidence, timing and risk factors. Cancers (Basel) 15(14). https://doi.org/10.3390/cancers15143548
Burkhardt JK, Zinn PO, Graenicher M, Santillan A, Bozinov O, Kasper EM et al (2011) Predicting postoperative hydrocephalus in 227 patients with skull base meningioma. Neurosurg Focus 30(5):E9. https://doi.org/10.3171/2011.3.Focus117
Sharma M, Ambekar S, Sonig A, Nanda A (2013) Factors predicting the development of new onset post-operative hydrocephalus following trans-sphenoidal Surgery for pituitary adenoma. Clin Neurol Neurosurg 115(10):1951–1954. https://doi.org/10.1016/j.clineuro.2013.05.020
Picart T, Dumot C, Meyronet D, Pallud J, Metellus P, Zouaoui S et al (2022) Characteristics and management of hydrocephalus in adult patients with cerebellar glioblastoma: lessons from a French nationwide series of 118 cases. Neurosurg Rev 45(1):683–699. https://doi.org/10.1007/s10143-021-01578-2
Toma AK, Papadopoulos MC, Stapleton S, Kitchen ND, Watkins LD (2013) Systematic review of the outcome of shunt Surgery in idiopathic normal-pressure hydrocephalus. Acta Neurochir (Wien) 155(10):1977–1980. https://doi.org/10.1007/s00701-013-1835-5
Paisan GM, Ding D, Starke RM, Crowley RW, Liu KC (2018) Shunt-Dependent Hydrocephalus after Aneurysmal Subarachnoid Hemorrhage: predictors and long-term functional outcomes. Neurosurgery 83(3):393–402. https://doi.org/10.1093/neuros/nyx393
Mansoor N, Solheim O, Fredriksli OA, Gulati S (2021) Revision and complication rates in adult shunt Surgery: a single-institution study. Acta Neurochir (Wien) 163(2):447–454. https://doi.org/10.1007/s00701-020-04526-z
Reddy GK, Bollam P, Caldito G (2014) Long-term outcomes of ventriculoperitoneal shunt Surgery in patients with hydrocephalus. World Neurosurg 81(2):404–410. https://doi.org/10.1016/j.wneu.2013.01.096
Hosainey SAM, Hald JK, Meling TR (2022) Risk of early failure of VP shunts implanted for hydrocephalus after craniotomies for brain tumors in adults. Neurosurg Rev 45(1):479–490. https://doi.org/10.1007/s10143-021-01549-7
Nyberg-Hansen R, Torvik A, Bhatia R (1975) On the pathology of experimental hydrocephalus. Brain Res 95(2–3):343–350. https://doi.org/10.1016/0006-8993(75)90111-0
Mistry AM, Kelly PD, Gallant JN, Mummareddy N, Mobley BC, Thompson RC et al (2019) Comparative Analysis of Subventricular Zone Glioblastoma Contact and Ventricular Entry during Resection in Predicting Dissemination, Hydrocephalus, and Survival. Clin Neurosurg 85(5):E924–E32. https://doi.org/10.1093/neuros/nyz144
Lu VM, Abou-Al-Shaar H, Bin-Alamer O, Luther EM, Benjamin CG (2023) Postoperative course of cerebrospinal fluid diversion in the setting of leptomeningeal Disease: a systematic review, meta-analysis, and meta-regression with an illustrative case. J Neurooncol 163(1):29–37. https://doi.org/10.1007/s11060-023-04334-2
Hana T, Tanaka S, Shin M, Mukasa A, Kugasawa K, Saito N (2015) Neuroendoscopic Ventriculocisternostomy with Stent Placement for Trapped Temporal Horn After the Resection of Glioblastoma. World Neurosurg. ;84(6):2078.e5-8. https://doi.org/10.1016/j.wneu.2015.08.019
Garcia-Bonilla M, Castaneyra-Ruiz L, Zwick S, Talcott M, Otun A, Isaacs AM et al (2022) Acquired hydrocephalus is associated with neuroinflammation, progenitor loss, and cellular changes in the subventricular zone and periventricular white matter. Fluids Barriers CNS 19(1):17. https://doi.org/10.1186/s12987-022-00313-3
Author information
Authors and Affiliations
Contributions
Victor M. Lu: Conceptualization, Data curation, Software, Visualization.Muhammet Enes Gurses: Data curation. All authors: Writing- Original draft preparation, Methodology, Investigation, Writing- Reviewing and Editing.
Corresponding author
Ethics declarations
Disclosures
All authors report no funding sources or conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lu, V.M., Khalafallah, A., Jaman, E. et al. Clinical course of ventriculoperitoneal shunting for hydrocephalus following glioblastoma surgery: a systematic review and meta-analysis. J Neurooncol 165, 439–447 (2023). https://doi.org/10.1007/s11060-023-04538-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-023-04538-6